[{"address1": "1035 Cambridge Street", "address2": "Suite 18A", "city": "Cambridge", "state": "MA", "zip": "02141", "country": "United States", "phone": "212 582 1199", "website": "https://eternatx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sandra M. Gurrola", "age": 56, "title": "Principal Financial & Accounting Officer and Senior VP of Finance", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 305883, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sanjeev  Luther", "age": 61, "title": "CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Hamilton Pierce M.D.", "age": 59, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dorothy J. Clarke", "age": 57, "title": "General Counsel & Director", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.65, "open": 1.66, "dayLow": 1.57, "dayHigh": 1.7732, "regularMarketPreviousClose": 1.65, "regularMarketOpen": 1.66, "regularMarketDayLow": 1.57, "regularMarketDayHigh": 1.7732, "beta": 7.843, "forwardPE": -0.17499998, "volume": 19908, "regularMarketVolume": 19908, "averageVolume": 7512, "averageVolume10days": 4410, "averageDailyVolume10Day": 4410, "marketCap": 9171422, "fiftyTwoWeekLow": 0.84, "fiftyTwoWeekHigh": 2.63, "priceToSalesTrailing12Months": 56.613716, "fiftyDayAverage": 1.8374, "twoHundredDayAverage": 1.8253, "currency": "USD", "enterpriseValue": 55896996, "floatShares": 2957536, "sharesOutstanding": 5410590, "sharesShort": 37055, "sharesShortPriorMonth": 51303, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.39310002, "heldPercentInstitutions": 0.0721, "shortRatio": 3.22, "shortPercentOfFloat": 0.009, "bookValue": -1.576, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -23936000, "trailingEps": -4.43, "forwardEps": -9.6, "enterpriseToRevenue": 345.043, "enterpriseToEbitda": -2.557, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ERNA", "underlyingSymbol": "ERNA", "shortName": "Eterna Therapeutics Inc.", "longName": "Eterna Therapeutics Inc.", "firstTradeDateEpochUtc": 683472600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "280db8c6-d665-3e8c-aebc-b7fe5ee139e0", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.68, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 2586000, "totalCashPerShare": 0.478, "ebitda": -21863000, "totalDebt": 49205000, "quickRatio": 0.293, "currentRatio": 0.373, "totalRevenue": 162000, "revenuePerShare": 0.03, "returnOnAssets": -0.29415, "freeCashflow": -11775750, "operatingCashflow": -16493000, "grossMargins": -1.11111, "operatingMargins": -104.914894, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]